175 related articles for article (PubMed ID: 18707027)
1. Hepatitis C virus-related arthritis.
Palazzi C; D'Angelo S; Olivieri I
Autoimmun Rev; 2008 Oct; 8(1):48-51. PubMed ID: 18707027
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatitis C virus-related arthritis.
Palazzi C; Olivieri I; Cacciatore P; Pennese E; D'Amico E
Expert Opin Pharmacother; 2005 Jan; 6(1):27-34. PubMed ID: 15709880
[TBL] [Abstract][Full Text] [Related]
3. An update on the management of hepatitis C virus-related arthritis.
Palazzi C; D'Amico E; D'Angelo S; Gilio M; Leccese P; Olivieri I
Expert Opin Pharmacother; 2014 Oct; 15(14):2039-45. PubMed ID: 25146875
[TBL] [Abstract][Full Text] [Related]
4. Renal manifestations associated with hepatitis C virus.
Sinico RA; Fornasieri A; D'Amico G
Ann Med Interne (Paris); 2000 Feb; 151(1):41-5. PubMed ID: 10761561
[TBL] [Abstract][Full Text] [Related]
5. HCV infection and extrahepatic manifestations.
Nocente R; Ceccanti M; Bertazzoni G; Cammarota G; Silveri NG; Gasbarrini G
Hepatogastroenterology; 2003; 50(52):1149-54. PubMed ID: 12846002
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus and arthritis.
Olivieri I; Palazzi C; Padula A
Rheum Dis Clin North Am; 2003 Feb; 29(1):111-22. PubMed ID: 12635503
[TBL] [Abstract][Full Text] [Related]
7. Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis.
Riccio A; Postiglione L; La Dogana P; Spanò A; Marzocchella C; Tarantino G
J Biol Regul Homeost Agents; 2008; 22(1):57-61. PubMed ID: 18394318
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients.
Galeazzi M; Bellisai F; Manganelli S; Morozzi G; Sebastiani GD
Autoimmun Rev; 2006 Aug; 5(7):493-8. PubMed ID: 16920576
[TBL] [Abstract][Full Text] [Related]
9. Management of hepatitis C virus-related arthritis.
Zuckerman E; Yeshurun D; Rosner I
BioDrugs; 2001; 15(9):573-84. PubMed ID: 11580301
[TBL] [Abstract][Full Text] [Related]
10. Natural history and therapy of 66 patients with mixed cryoglobulinemia.
Bryce AH; Kyle RA; Dispenzieri A; Gertz MA
Am J Hematol; 2006 Jul; 81(7):511-8. PubMed ID: 16755564
[TBL] [Abstract][Full Text] [Related]
11. Extrahepatic manifestations of chronic HCV infection.
Galossi A; Guarisco R; Bellis L; Puoti C
J Gastrointestin Liver Dis; 2007 Mar; 16(1):65-73. PubMed ID: 17410291
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus associated arthritis in absence of clinical, biochemical and histological evidence of liver disease--responding to interferon therapy.
Akhtar AJ; Funnyé AS
Med Sci Monit; 2005 Jul; 11(7):CS37-9. PubMed ID: 15990694
[TBL] [Abstract][Full Text] [Related]
13. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon.
Nissen MJ; Fontanges E; Allam Y; Zoulim F; Trépo C; Miossec P
Rheumatology (Oxford); 2005 Aug; 44(8):1016-20. PubMed ID: 15855185
[TBL] [Abstract][Full Text] [Related]
14. Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection.
Galeazzi M; Bellisai F; Giannitti C; Manganelli S; Morozzi G; Sebastiani GD
Ann N Y Acad Sci; 2007 Sep; 1110():544-9. PubMed ID: 17911470
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.
Perotti M; Ghidoli N; Altara R; Diotti RA; Clementi N; De Marco D; Sassi M; Clementi M; Burioni R; Mancini N
Autoimmun Rev; 2008 Jun; 7(6):468-72. PubMed ID: 18558364
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.
Lo KY; Chen CY; Lee CS
Ren Fail; 2009; 31(2):149-52. PubMed ID: 19212913
[TBL] [Abstract][Full Text] [Related]
17. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
18. Acute hepatitis C: prevention and treatment.
Ozaras R; Tahan V
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
[TBL] [Abstract][Full Text] [Related]
19. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of HCV induced B-cell clonal disorders.
Landau DA; Saadoun D; Calabrese LH; Cacoub P
Autoimmun Rev; 2007 Sep; 6(8):581-7. PubMed ID: 17854753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
